Financials
- Market Capitalization 2.72 M
- Employee 2
- Founded 2007
- CEO N/A
- Website www.propanc.com
- Headquarter Delaware, United States
- FIGI BBG002086386
- Industry İlaç Üreticileri - Genel
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.09
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4759 | APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 4.36 USD | -15.01% | -38.85% | +102.79% | +232.82% | 6.58 M USD | ||
| 4846 | QCLS Q/C Technologies, Inc. - Common Stock | 0.56 USD | -3.45% | -22.22% | -65.00% | -85.42% | 4.59 M USD | ||
| 4916 | KAPA Kairos Pharma, Ltd. Common Stock | 0.81 USD | -2.41% | -34.68% | -52.63% | +39.66% | 2.74 M USD | ||
| 4921 | VIVS VivoSim Labs, Inc. - Common Stock | 0.18 USD | +5.88% | -14.29% | -37.93% | -90.58% | 2.67 M USD |